Full Fed. Circ. Won't Review $61M Enzo Patent Ruling
The full Federal Circuit on Friday refused a bid by Enzo Biochem Inc. to a review a decision that threw out its $61 million patent victory against a Thermo Fisher Scientific...To view the full article, register now.
Already a subscriber? Click here to view full article